\-\ Texto\\:\\ \ \(0\)\
\-\ neck\\ pain\\ elicited\\ with\\ full\\ flexion\\ of\\ neck\\.\\ \\ neuro\\ exam\\ intact\\,\\ alert\\ and\\ oriented\\,\\ rest\\ of\\ exam\\ within\\ normal\\ limits\\.\\ \\ blood\\ and\\ csf\\ cultures\\ negative\\.\\ \\ csf\\ analysis\\ rbc\\ 38\\ wbc\\ 218\\ 98\\%\\ segs\\ gluc\\ 27\\ protein\\ 68\\.\\ \\ abscess\\ culture\\ with\\ scant\\ growth\\ of\\ streptococcus\\ intermedius\\.\ \(0\)\
\-\ initially\\ treated\\ empirically\\ with\\ parenteral\\ rocephin\\ and\\ vancomycin\\.\\ \\ rocephin\\ was\\ changed\\ to\\ merrem\\.\\ \\ treatment\\ will\\ be\\ continued\\ for\\ 4\\ to\\ 6\\ weeks\\.\\ \\ follow\\-up\\ mri\\ 3\\ weeks\\ after\\ discharge\\ from\\ hospital\\.\ \(0\)\
\-\ initial\\ ct\\ head\\ with\\ and\\ without\\ contrast\\ revealed\\ multiple\\ ring\\-enhancing\\ lesions\\ scattered\\ throughout\\ the\\ supratentorial\\ brain\\.\\ \\ \ \(0\)\
\-\ mri\\ revealed\\ multiple\\ ring\\-enhancing\\ lesions\\ throughout\\ the\\ brain\\ bilaterally\\.\ \(0\)\
\-\ multifocal\\ brain\\ abscess\ \(0\)\
\-\ hematogenous\\ \\(most\\ likely\\)\\ vs\\ contagenous\\ spread\\.\\ \\ etiology\\ due\\ to\\ tb\\,\\ opportunistic\\ infections\\,\\ neurocysticercosis\\,\\ cryptococcosis\\,\\ metastasis\\,\\ multiple\\ sclerosis\\,\\ iv\\ drug\\ use\\,\\ sinusitis\\,\\ dental\\ infection\\,\\ endocarditis\\,\\ pulmonary\\ infection\\,\\ abdominal\\ infection\\.\ \(0\)\
\-\ 17\\ y\\/o\\ man\\ with\\ fevers\\ to\\ 42\\.4\\ degrees\\ celsius\\ and\\ headache\\ s\\/p\\ 7\\ days\\ of\\ parenteral\\ antibiotics\\ for\\ meningitis\\ worsening\\ clinically\\.\ \(0\)\
\-\ the\\ patient\\ began\\ responding\\ to\\ parenteral\\ antibiotics\\.\\ \\ he\\ was\\ later\\ discharged\\ home\\ on\\ antibiotics\\ with\\ follow\\-up\\ mri\\ in\\ 3\\ weeks\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parenteral\\:\\ 0\\.09780729822606322\ \(0\)\
\-\ rocephin\\:\\ 0\\.07099586710869357\ \(0\)\
\-\ ring\\-enhancing\\:\\ 0\\.06237055935151229\ \(0\)\
\-\ antibiotics\\:\\ 0\\.04743423188675617\ \(0\)\
\-\ 68\\.\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ merrem\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ contagenous\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ 42\\.4\\:\\ 0\\.040011681002002725\ \(0\)\
\-\ brain\\:\\ 0\\.0380002688172822\ \(0\)\
\-\ infection\\:\\ 0\\.03670960454294789\ \(0\)\
\-\ 218\\:\\ 0\\.03659716287116555\ \(0\)\
\-\ opportunistic\\:\\ 0\\.03659716287116555\ \(0\)\
\-\ weeks\\:\\ 0\\.035841543205435686\ \(0\)\
\-\ cryptococcosis\\:\\ 0\\.035497933554346786\ \(0\)\
\-\ celsius\\:\\ 0\\.035497933554346786\ \(0\)\
\-\ csf\\:\\ 0\\.03515757982074889\ \(0\)\
\-\ segs\\:\\ 0\\.034599797806593315\ \(0\)\
\-\ gluc\\:\\ 0\\.034599797806593315\ \(0\)\
\-\ empirically\\:\\ 0\\.033182644740328386\ \(0\)\
\-\ scant\\:\\ 0\\.03161390714861147\ \(0\)\
\-\ neurocysticercosis\\:\\ 0\\.03161390714861147\ \(0\)\
\-\ throughout\\:\\ 0\\.03151475198325051\ \(0\)\
\-\ intermedius\\:\\ 0\\.031185279675756145\ \(0\)\
\-\ responding\\:\\ 0\\.031185279675756145\ \(0\)\
\-\ mri\\:\\ 0\\.02901392889036384\ \(0\)\
\-\ vancomycin\\:\\ 0\\.02892157361970472\ \(0\)\
\-\ endocarditis\\:\\ 0\\.028668897292672448\ \(0\)\
\-\ streptococcus\\:\\ 0\\.028199389017774298\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.027389527009278245\ \(0\)\
\-\ supratentorial\\:\\ 0\\.02719054954661167\ \(0\)\
\-\ hematogenous\\:\\ 0\\.02719054954661167\ \(0\)\
\-\ revealed\\:\\ 0\\.027019447190798948\ \(0\)\
\-\ elicited\\:\\ 0\\.02667153222810021\ \(0\)\
\-\ changed\\:\\ 0\\.02667153222810021\ \(0\)\
\-\ abscess\\:\\ 0\\.02661907629688933\ \(0\)\
\-\ multiple\\:\\ 0\\.02659811827801875\ \(0\)\
\-\ dental\\:\\ 0\\.026353608478654048\ \(0\)\
\-\ 98\\:\\ 0\\.026054965021430232\ \(0\)\
\-\ neck\\:\\ 0\\.02472160726126584\ \(0\)\
\-\ sinusitis\\:\\ 0\\.02435624341408181\ \(0\)\
\-\ rbc\\:\\ 0\\.02425467057071858\ \(0\)\
\-\ multifocal\\:\\ 0\\.022640446890593063\ \(0\)\
\-\ lesions\\:\\ 0\\.02253754193442313\ \(0\)\
\-\ 38\\:\\ 0\\.022427776093227502\ \(0\)\
\-\ culture\\:\\ 0\\.022427776093227502\ \(0\)\
\-\ meningitis\\:\\ 0\\.02183986103099811\ \(0\)\
\-\ neuro\\:\\ 0\\.021718222545331255\ \(0\)\
\-\ cultures\\:\\ 0\\.021658511409703943\ \(0\)\
\-\ protein\\:\\ 0\\.021599515394695488\ \(0\)\
\-\ drug\\:\\ 0\\.021599515394695488\ \(0\)\
\-\ analysis\\:\\ 0\\.021426651750304997\ \(0\)\
\-\ degrees\\:\\ 0\\.02137035275609996\ \(0\)\
\-\ began\\:\\ 0\\.021314689922336743\ \(0\)\
\-\ alert\\:\\ 0\\.020993308041211613\ \(0\)\
\-\ oriented\\:\\ 0\\.020643081826020822\ \(0\)\
\-\ 17\\:\\ 0\\.020500286077876725\ \(0\)\
\-\ discharge\\:\\ 0\\.020407337879332965\ \(0\)\
\-\ spread\\:\\ 0\\.020361513284937332\ \(0\)\
\-\ tb\\:\\ 0\\.02027112343928119\ \(0\)\
\-\ infections\\:\\ 0\\.020009498684040068\ \(0\)\
\-\ fevers\\:\\ 0\\.020009498684040068\ \(0\)\
\-\ home\\:\\ 0\\.020009498684040068\ \(0\)\
\-\ 3\\:\\ 0\\.019714044598093988\ \(0\)\
\-\ scattered\\:\\ 0\\.019602150330123254\ \(0\)\
\-\ 27\\:\\ 0\\.01952457221697971\ \(0\)\
\-\ rest\\:\\ 0\\.019410448772243086\ \(0\)\
\-\ flexion\\:\\ 0\\.019372987691527722\ \(0\)\
\-\ discharged\\:\\ 0\\.019298909477909295\ \(0\)\
\-\ exam\\:\\ 0\\.01849491566452747\ \(0\)\
\-\ clinically\\:\\ 0\\.018456227693331363\ \(0\)\
\-\ growth\\:\\ 0\\.018303704414494085\ \(0\)\
\-\ full\\:\\ 0\\.018184997263858322\ \(0\)\
\-\ continued\\:\\ 0\\.018126699442937124\ \(0\)\
\-\ etiology\\:\\ 0\\.01781783937290972\ \(0\)\
\-\ s\\/p\\:\\ 0\\.017657191168038974\ \(0\)\
\-\ limits\\:\\ 0\\.01735080590759609\ \(0\)\
\-\ \\,\\:\\ 0\\.01733611257007259\ \(0\)\
\-\ initially\\:\\ 0\\.017132908099828474\ \(0\)\
\-\ use\\:\\ 0\\.016637631108587698\ \(0\)\
\-\ vs\\:\\ 0\\.0165737929576394\ \(0\)\
\-\ worsening\\:\\ 0\\.0165737929576394\ \(0\)\
\-\ 7\\:\\ 0\\.016129334378364887\ \(0\)\
\-\ hospital\\:\\ 0\\.015847765837281397\ \(0\)\
\-\ metastasis\\:\\ 0\\.015757375991625255\ \(0\)\
\-\ intact\\:\\ 0\\.015461894688168555\ \(0\)\
\-\ iv\\:\\ 0\\.015361699199315734\ \(0\)\
\-\ wbc\\:\\ 0\\.01534519630825523\ \(0\)\
\-\ later\\:\\ 0\\.015199106605876473\ \(0\)\
\-\ sclerosis\\:\\ 0\\.015119779475006626\ \(0\)\
\-\ headache\\:\\ 0\\.01445805634268866\ \(0\)\
\-\ initial\\:\\ 0\\.013948680508765065\ \(0\)\
\-\ bilaterally\\:\\ 0\\.013826134179920705\ \(0\)\
\-\ will\\:\\ 0\\.013169857233394788\ \(0\)\
\-\ days\\:\\ 0\\.01290184382350728\ \(0\)\
\-\ treated\\:\\ 0\\.01260025042405842\ \(0\)\
\-\ negative\\:\\ 0\\.012572020499383618\ \(0\)\
\-\ 6\\:\\ 0\\.012572020499383618\ \(0\)\
\-\ pulmonary\\:\\ 0\\.012298277390246618\ \(0\)\
\-\ head\\:\\ 0\\.01193892271218668\ \(0\)\
\-\ likely\\:\\ 0\\.011873349585889934\ \(0\)\
\-\ he\\:\\ 0\\.011744765231689751\ \(0\)\
\-\ 4\\:\\ 0\\.011728925641276085\ \(0\)\
\-\ y\\/o\\:\\ 0\\.011658271082855373\ \(0\)\
\-\ blood\\:\\ 0\\.01148970971679458\ \(0\)\
\-\ due\\:\\ 0\\.011232892379078027\ \(0\)\
\-\ abdominal\\:\\ 0\\.01052176964592175\ \(0\)\
\-\ to\\:\\ 0\\.010518918927167149\ \(0\)\
\-\ man\\:\\ 0\\.009955329276305415\ \(0\)\
\-\ without\\:\\ 0\\.009911394908168277\ \(0\)\
\-\ \\%\\:\\ 0\\.009819315435202008\ \(0\)\
\-\ was\\:\\ 0\\.009736724356785091\ \(0\)\
\-\ most\\:\\ 0\\.009718399712946187\ \(0\)\
\-\ contrast\\:\\ 0\\.009422540329102983\ \(0\)\
\-\ after\\:\\ 0\\.008709365530094593\ \(0\)\
\-\ treatment\\:\\ 0\\.00852028058916693\ \(0\)\
\-\ within\\:\\ 0\\.008030203982197446\ \(0\)\
\-\ for\\:\\ 0\\.007183331513721331\ \(0\)\
\-\ normal\\:\\ 0\\.006599076131030055\ \(0\)\
\-\ be\\:\\ 0\\.006491412430265661\ \(0\)\
\-\ from\\:\\ 0\\.006238599572188238\ \(0\)\
\-\ ct\\:\\ 0\\.005888195336906615\ \(0\)\
\-\ pain\\:\\ 0\\.00514092693364894\ \(0\)\
\-\ and\\:\\ 0\\.004433719353010307\ \(0\)\
\-\ patient\\:\\ 0\\.0042196646843171825\ \(0\)\
\-\ on\\:\\ 0\\.0035659655781548182\ \(0\)\
\-\ \\(\\:\\ 0\\.0035584321489845346\ \(0\)\
\-\ \\)\\:\\ 0\\.003514964000558153\ \(0\)\
\-\ with\\:\\ 0\\.003458251510046002\ \(0\)\
\-\ \\.\\:\\ 0\\.002623118430838395\ \(0\)\
\-\ of\\:\\ 0\\.0022956413950342546\ \(0\)\
\-\ in\\:\\ 0\\.002075848424336231\ \(0\)\
\-\ the\\:\\ 0\\.0020430928773934845\ \(0\)\
